Not all individuals with CLL need therapy. Regardless of all modern advances, the iwCLL still endorses watchful observation for individuals with asymptomatic disorder.86 This advice is predicated on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both… Read More